JPWO2021243016A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021243016A5 JPWO2021243016A5 JP2022562966A JP2022562966A JPWO2021243016A5 JP WO2021243016 A5 JPWO2021243016 A5 JP WO2021243016A5 JP 2022562966 A JP2022562966 A JP 2022562966A JP 2022562966 A JP2022562966 A JP 2022562966A JP WO2021243016 A5 JPWO2021243016 A5 JP WO2021243016A5
- Authority
- JP
- Japan
- Prior art keywords
- dosage
- analyte
- group
- medication
- user
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229940079593 drug Drugs 0.000 claims description 233
- 239000003814 drug Substances 0.000 claims description 233
- 239000012491 analyte Substances 0.000 claims description 212
- 230000009471 action Effects 0.000 claims description 164
- 238000012360 testing method Methods 0.000 claims description 136
- 239000000126 substance Substances 0.000 claims description 131
- 238000000034 method Methods 0.000 claims description 124
- 238000012545 processing Methods 0.000 claims description 95
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 78
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 76
- 239000008103 glucose Substances 0.000 claims description 76
- 235000012054 meals Nutrition 0.000 claims description 70
- 238000005259 measurement Methods 0.000 claims description 62
- 102000004877 Insulin Human genes 0.000 claims description 39
- 108090001061 Insulin Proteins 0.000 claims description 39
- 229940125396 insulin Drugs 0.000 claims description 39
- 230000015654 memory Effects 0.000 claims description 27
- 235000021152 breakfast Nutrition 0.000 claims description 18
- 235000021158 dinner Nutrition 0.000 claims description 16
- 235000021156 lunch Nutrition 0.000 claims description 16
- 235000013305 food Nutrition 0.000 claims description 14
- 230000000694 effects Effects 0.000 claims description 13
- 230000008451 emotion Effects 0.000 claims description 8
- 238000004891 communication Methods 0.000 description 46
- 238000012544 monitoring process Methods 0.000 description 44
- 238000007726 management method Methods 0.000 description 38
- 230000000875 corresponding effect Effects 0.000 description 25
- 230000002218 hypoglycaemic effect Effects 0.000 description 25
- 238000002347 injection Methods 0.000 description 25
- 239000007924 injection Substances 0.000 description 25
- 208000013016 Hypoglycemia Diseases 0.000 description 23
- 230000000291 postprandial effect Effects 0.000 description 21
- 238000001727 in vivo Methods 0.000 description 17
- 230000006870 function Effects 0.000 description 15
- 206010012601 diabetes mellitus Diseases 0.000 description 14
- 238000012377 drug delivery Methods 0.000 description 14
- 238000010586 diagram Methods 0.000 description 10
- 230000005540 biological transmission Effects 0.000 description 9
- 238000000338 in vitro Methods 0.000 description 9
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 150000001720 carbohydrates Chemical class 0.000 description 6
- 235000014633 carbohydrates Nutrition 0.000 description 6
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 5
- 229940127560 insulin pen Drugs 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- 210000001124 body fluid Anatomy 0.000 description 4
- 210000003722 extracellular fluid Anatomy 0.000 description 4
- 238000012552 review Methods 0.000 description 4
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 239000004065 semiconductor Substances 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 241000220225 Malus Species 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 230000002641 glycemic effect Effects 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000010079 rubber tapping Methods 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
- 230000004584 weight gain Effects 0.000 description 2
- 235000019786 weight gain Nutrition 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 208000001145 Metabolic Syndrome Diseases 0.000 description 1
- 208000017442 Retinal disease Diseases 0.000 description 1
- 206010038923 Retinopathy Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 1
- 239000012790 adhesive layer Substances 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 235000021074 carbohydrate intake Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000036433 growing body Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 238000010295 mobile communication Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 230000007823 neuropathy Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 208000033808 peripheral neuropathy Diseases 0.000 description 1
- 239000004984 smart glass Substances 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063032094P | 2020-05-29 | 2020-05-29 | |
| US63/032,094 | 2020-05-29 | ||
| PCT/US2021/034510 WO2021243016A1 (en) | 2020-05-29 | 2021-05-27 | Systems, devices, and methods for dosing pattern management |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023528157A JP2023528157A (ja) | 2023-07-04 |
| JPWO2021243016A5 true JPWO2021243016A5 (zh) | 2024-05-30 |
Family
ID=76921290
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022562966A Pending JP2023528157A (ja) | 2020-05-29 | 2021-05-27 | 投薬パターンを管理するためのシステム、デバイス、及び方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230207090A1 (zh) |
| EP (1) | EP4158643A1 (zh) |
| JP (1) | JP2023528157A (zh) |
| CN (1) | CN115917661A (zh) |
| AU (1) | AU2021279026A1 (zh) |
| CA (1) | CA3175567A1 (zh) |
| WO (1) | WO2021243016A1 (zh) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10136816B2 (en) | 2009-08-31 | 2018-11-27 | Abbott Diabetes Care Inc. | Medical devices and methods |
| US20180197628A1 (en) * | 2017-01-11 | 2018-07-12 | Abbott Diabetes Care Inc. | Systems, devices, and methods for experiential medication dosage calculations |
| WO2018152241A1 (en) | 2017-02-15 | 2018-08-23 | Abbott Diabetes Care Inc. | Systems, devices, and methods for integration of an analyte data reader and medication delivery device |
| CA3147267A1 (en) | 2019-08-02 | 2021-02-11 | Abbott Diabetes Care Inc. | Systems, devices, and methods relating to medication dose guidance |
-
2021
- 2021-05-27 US US17/925,692 patent/US20230207090A1/en active Pending
- 2021-05-27 EP EP21742206.2A patent/EP4158643A1/en active Pending
- 2021-05-27 WO PCT/US2021/034510 patent/WO2021243016A1/en unknown
- 2021-05-27 AU AU2021279026A patent/AU2021279026A1/en active Pending
- 2021-05-27 JP JP2022562966A patent/JP2023528157A/ja active Pending
- 2021-05-27 CA CA3175567A patent/CA3175567A1/en active Pending
- 2021-05-27 CN CN202180039156.9A patent/CN115917661A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9339219B2 (en) | Devices, systems, and methods related to analyte monitoring and management | |
| US11004566B2 (en) | Systems, devices, and methods for episode detection and evaluation | |
| US20180197628A1 (en) | Systems, devices, and methods for experiential medication dosage calculations | |
| US20210030323A1 (en) | Systems, devices, and methods for meal information collection, meal assessment, and analyte data correlation | |
| CA2987400A1 (en) | Wireless analyte monitoring | |
| CN115769303A (zh) | 用于膳食信息收集、膳食评估和分析物数据相关性的系统、设备和方法 | |
| US20220248988A1 (en) | Digital and user interfaces for analyte monitoring systems | |
| US20210282672A1 (en) | Graphical user interfaces for analyte monitoring systems | |
| US20220059215A1 (en) | Systems, devices and methods for improved meal and therapy interfaces in analyte monitoring systems | |
| JP2023528157A (ja) | 投薬パターンを管理するためのシステム、デバイス、及び方法 | |
| JPWO2021243016A5 (zh) | ||
| US20230404441A1 (en) | Systems, devices, and methods for meal-related analyte response monitoring | |
| US20240090852A1 (en) | Analyte monitoring systems and methods | |
| US20240099612A1 (en) | Systems, devices, and methods for dual analyte sensor | |
| CA3238339A1 (en) | Systems, devices, and methods for wellness monitoring with physiological sensors | |
| WO2023086270A1 (en) | Systems, devices, and methods of using blockchain for tracking patient identification |